Who was studied, and how
Three numbers in the abstract
Where each one falls
Where it lands on the map
343people in the Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes trial, from 2014
18of them with type 2 diabetes, in this paper
The trial randomly assignedassigned by chance
liraglutide
sulphonylurea
Probably lowered body weight−0.54
Probably lowered long-term blood sugar−0.59
No clear effect on fructosamine levels+3.51
randomisedthe abstract, start to end
… estimated treatment difference (ETD) 3.51 µmol/L (95% CI: -5.26; 12.28); …
… during Ramadan with liraglutide (ETD: -0.54 kg; 95% CI: -0.94;-0.14; …
… led to greater HbA1c reduction [ETD: -0.59% (-6.40 mmol/mol), 95% CI: …
← favours treatmentfavours comparator →
could be chanceFructosamine levelsliraglutide vs sulphonylurea
3.51−5.26 to 12.3
Body weightliraglutide vs sulphonylurea
−0.54−0.94 to −0.14
HbA1cliraglutide vs sulphonylurea
−0.59−0.79 to −0.38
GLP-1 receptor agonistsGlycemic controlBody weight & composition
1 / 4